Top Stories

European Union approves Pfizer’s Kovid vaccine for children aged 5 to 11

Covid VaccineThe European Medicines Agency (EU) on Thursday approved Pfizer Company’s anti-Kovid-19 vaccine for children aged 5 to 11 years. With this, the way has been cleared for the Kovid vaccination of millions of school children amid the increase in new cases of corona virus in Europe.

The European Union, consisting of 27 countries, has already approved the vaccine for use in people 12 years of age and older. Prior to this, Pfizer Company has so far been approved to vaccinate children between the ages of 5 and 11 in the United States of America, Israel and Canada.

According to the EMA, children between the ages of 5 and 11 will be given two injections spaced three weeks apart with a third of the dose. This is the first time that the EMA has approved a Kovid vaccine for the vaccination of children. In the vaccine trial, in a study conducted on about 2,000 children aged 5 to 11 years, this vaccine was 90.7 percent effective. At the same time, the side effects after vaccination include pain in the injection site, fatigue, headache, muscle pain and chills.

It is worth noting that officials in the Netherlands said earlier this week that the highest increase in cases was in children up to the age of 12. The regulator has so far approved four vaccines for use in the European Union.

Interpol: Interpol elected UAE official as its President, Indian officials were also elected in the Apex Committee

Italy COVID-19: Restrictions will be imposed on people who do not get vaccinated in Italy, vaccination certificate will have to be shown in hotels and cinema halls


Leave a Reply

Your email address will not be published. Required fields are marked *